Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments

Bock, H; Juretzek, T; Handreka, R; Ruhnau, J; Lobel, M; Reuner, K; Peltroche, H; Dressel, A

Dressel, A (通讯作者),Carl Thiem Hosp Cottbus, Dept Neurol, Cottbus, Germany.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022; 59 ():

Abstract

Background: Vaccination against SARS CoV-2 results in excellent personal protection against a severe course of COVID19. In People with Multiple Sclero......

Full Text Link